Novel Viral Vaccine and Molecular Immunology
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cellular/Molecular Immunology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 1331
Special Issue Editor
2. Changchun Institute of Veterinary Medicine, Chinese Academy of Agricultural Sciences, Changchun 130122, China
Interests: viral infection and immunity; viral–host interaction; viral diagnosis; viral vaccine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Viral infections pose a serious threat to public health, and vaccines are the most effective and affordable measures to control them. New technologies and vaccines are being developed, including DNA vaccines, mRNA vaccines, multi-epitope vaccines, synthetic peptide vaccines, vaccines targeting dendritic cells, and mucosal vaccines. However, safety, effectiveness, controllability, and cost remain concerns, and the continuous mutation of viruses is an ongoing challenge. We welcome your latest research on developing novel technologies and vaccines against viral infections, including clinical trials, molecular immunology, and new strategies. Research areas include designing and evaluating vaccines, developing universal vaccines, identifying immunogen targets of viruses, developing new tools for predicting antigens and their application and studying the immune mechanism of vaccines, especially mucosal vaccines.
Dr. Chang Li
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral infectious diseases
- novel vaccines
- immune mechanism
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
